Transcatheter aortic valve replacement in patients with pure native aortic valve regurgitation: A systematic review and meta-analysis.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 20 08 2018
revised: 16 10 2018
accepted: 19 10 2018
pubmed: 24 10 2018
medline: 2 5 2019
entrez: 24 10 2018
Statut: ppublish

Résumé

This systematic review and meta-analysis sought to summarize the available evidence on the use of transcatheter aortic valve replacement (TAVR) in patients with Native Aortic Valve Regurgitation (NAVR) and compare outcomes between first and second generation valves. Owing to the improvements in transcatheter heart valve design and procedural success, TAVR has become increasingly performed in broader aortic valve pathologies. We searched Medline, Embase, Cochrane, and Scopus databases from 2007 to 2018 and performed a systematic review on reports with at least 10 patients with aortic valve regurgitation undergoing TAVR procedure. The main outcome of interest was all-cause mortality at 30 days. A total of 638 patients across 12 studies were included. Mean age ranged from 68 to 84. Society of Thoracic Surgeons score ranged from 5.4% to 13.1% and Logistic EuroSCORE ranged from 18.2% to 33%. The incidence rate of all-cause mortality at 30 days was found to be 11% (95% CI 7%-16%; I

Identifiants

pubmed: 30350358
doi: 10.1002/clc.23103
pmc: PMC6436518
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-166

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Références

PLoS One. 2010 Apr 21;5(4):e10271
pubmed: 20422014
Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44
pubmed: 22922698
Int J Cardiol. 2017 Oct 15;245:83-89
pubmed: 28760396
Eur Heart J. 2003 Jul;24(13):1231-43
pubmed: 12831818
JAMA Cardiol. 2017 Aug 1;2(8):846-854
pubmed: 28636718
Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):388-93
pubmed: 24893871
Catheter Cardiovasc Interv. 2018 Jun;91(7):1345-1351
pubmed: 29171730
Eur Heart J. 2012 Oct;33(19):2451-96
pubmed: 22922415
JACC Cardiovasc Interv. 2017 May 22;10(10):1048-1056
pubmed: 28521923
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8
pubmed: 23963506
EuroIntervention. 2014 Oct;10(6):739-45
pubmed: 25330506
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Thorac Cardiovasc Surg. 2010 Oct;140(4):930-2
pubmed: 20381075
Eur Heart J. 2007 Jan;28(2):230-68
pubmed: 17259184
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1842-9
pubmed: 26604062
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
J Am Coll Cardiol. 2013 Apr 16;61(15):1577-84
pubmed: 23433565
Clin Cardiol. 2019 Jan;42(1):159-166
pubmed: 30350358
Eur J Cardiothorac Surg. 2012 Nov;42(5):S45-60
pubmed: 23026738
J Invasive Cardiol. 2015 May;27(5):229-36
pubmed: 25929299
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1777-96
pubmed: 26718509
JACC Cardiovasc Interv. 2016 Nov 28;9(22):2308-2317
pubmed: 28026742
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
J Thorac Cardiovasc Surg. 2018 Feb;155(2):588-597
pubmed: 28992963
J Am Coll Cardiol. 2017 Dec 5;70(22):2752-2763
pubmed: 29191323
JACC Cardiovasc Interv. 2014 Oct;7(10):1168-74
pubmed: 25129672
Circulation. 2002 Dec 10;106(24):3006-8
pubmed: 12473543
Clin Cardiol. 2018 Jul;41(7):896-902
pubmed: 29896777
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
Can J Cardiol. 2016 Feb;32(2):266-9
pubmed: 26481084
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Abdullah Haddad (A)

Division of Cardiology, Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania. Harvard T.H Chan School of Public Health, Boston, Massachusetts.

Remy Arwani (R)

Ain Shams University-Faculty of Medicine, Cairo, Egypt.

Osama Altayar (O)

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

Tarek Sawas (T)

Department of Medicine, Mayo Clinic, Rochester, Minnesota.

M Hassan Murad (MH)

Evidence-based Practice Center, Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.

Eduardo de Marchena (E)

Division of Cardiology, University of Miami-Miller School of Medicine, Miami, Florida.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH